GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Effective Interest Rate on Debt %

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Effective Interest Rate on Debt % : 16.00% (As of Sep. 2019)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. OWC Pharmaceutical Research's annualized positive value of Interest Expense for the quarter that ended in Sep. 2019 was $0.01 Mil. OWC Pharmaceutical Research's average total debt for the quarter that ended in Sep. 2019 was $0.05 Mil. Therefore, OWC Pharmaceutical Research's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2019 was 16.00%.


OWC Pharmaceutical Research Effective Interest Rate on Debt % Historical Data

The historical data trend for OWC Pharmaceutical Research's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Effective Interest Rate on Debt % Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only 3.66 - 75.60 2.00 -

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 13.33 35.40 16.00

Competitive Comparison of OWC Pharmaceutical Research's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OWC Pharmaceutical Research's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's Effective Interest Rate on Debt % falls into.



OWC Pharmaceutical Research Effective Interest Rate on Debt % Calculation

OWC Pharmaceutical Research's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2018 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2017 )+Total Debt  (A: Dec. 2018 ))/ count )
=-1  *  -0.003/( (0+0)/ 1 )
=-1  *  -0.003/0
=N/A %

where

OWC Pharmaceutical Research's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2019 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2019 )+Total Debt  (Q: Sep. 2019 ))/ count )
=-1  *  -0.008/( (0.053+0.047)/ 2 )
=-1  *  -0.008/0.05
=16.00 %

where

Total Debt  (Q: Jun. 2019 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.027 + 0.026
=0.053

Total Debt  (Q: Sep. 2019 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.021 + 0.026
=0.047

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2019) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


OWC Pharmaceutical Research  (OTCPK:OWCP) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


OWC Pharmaceutical Research Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines

From GuruFocus